Disclosed positions

Estimated from their latest filings — positions may have changed since

$11.01M

combined est. value

Stock	Shares	Price	Value	Weight	As of
BCAXBicara Therapeutics Inc.	362,152	$30.40	$11.01M	100%	2026-05-18

BCAX

Bicara Therapeutics Inc.

$11.01M

362,152 sh

All filings on record

Every Form 4 transaction we track for this filer

all 12buys 0sells 6

Stock	Transaction	Date	~6mo later
BCAXBicara Therapeutics Inc.	Sell $60.6K · 2,978 sh	2026-05-18	—
BCAXBicara Therapeutics Inc.	Sell $240.0K · 12,022 sh	2026-05-18	—
BCAXBicara Therapeutics Inc.	Exercise $56.8K · 15,000 sh	2026-05-18	—
BCAXBicara Therapeutics Inc.	Exercise $160.9K · 29,500 sh	2025-12-16	—
BCAXBicara Therapeutics Inc.	Sell $776.4K · 41,163 sh	2025-11-24	—
BCAXBicara Therapeutics Inc.	Exercise $156.0K · 41,163 sh	2025-11-24	—
BCAXBicara Therapeutics Inc.	Sell $453.8K · 24,103 sh	2025-10-16	—
BCAXBicara Therapeutics Inc.	Exercise $91.3K · 24,103 sh	2025-10-16	—
BCAXBicara Therapeutics Inc.	Sell $250.4K · 13,289 sh	2025-10-15	—
BCAXBicara Therapeutics Inc.	Exercise $50.4K · 13,289 sh	2025-10-15	—
BCAXBicara Therapeutics Inc.	Sell $216.5K · 11,445 sh	2025-10-13	—
BCAXBicara Therapeutics Inc.	Exercise $43.4K · 11,445 sh	2025-10-13	—

BCAXSell

2026-05-18 · Bicara Therapeutics Inc.

$60.6K

—

BCAXSell

2026-05-18 · Bicara Therapeutics Inc.

$240.0K

—

BCAXExercise

2026-05-18 · Bicara Therapeutics Inc.

$56.8K

—

BCAXExercise

2025-12-16 · Bicara Therapeutics Inc.

$160.9K

—

BCAXSell

2025-11-24 · Bicara Therapeutics Inc.

$776.4K

—

BCAXExercise

2025-11-24 · Bicara Therapeutics Inc.

$156.0K

—

BCAXSell

2025-10-16 · Bicara Therapeutics Inc.

$453.8K

—

BCAXExercise

2025-10-16 · Bicara Therapeutics Inc.

$91.3K

—

BCAXSell

2025-10-15 · Bicara Therapeutics Inc.

$250.4K

—

BCAXExercise

2025-10-15 · Bicara Therapeutics Inc.

$50.4K

—

BCAXSell

2025-10-13 · Bicara Therapeutics Inc.

$216.5K

—

BCAXExercise

2025-10-13 · Bicara Therapeutics Inc.

$43.4K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.